Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| (NASDAQ: DMRA) | Delayed: 21.28 -0.21 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.49 | 52 Week High | $ | |||
| Open | $21.75 | 52 Week Low | $ | |||
| Day High | $21.94 | P/E | N/A | |||
| Day Low | $20.75 | EPS | $ | |||
| Volume | 309,427 | |||||
